The function and metabolism of hearts removed from diabetic rats and subsequently . perfused in vitro were investigated. Diabetic hearts perfused under aerobic conditions had higher tissue levels of total CoA and long-chain acyl-CoA, lower levels of total camitine, but higher levels of long-chain acyl camitine esters, and used glucose at slower rates than did normal hearts. At low levels of cardiac work, mechanical function of the diabetic hearts was not significantly different than normal hearts for perfusion periods of up to 65 minutes. A mild form of whole heart ischemia (i.e., a 50% reduction in coronary flow) was tolerated just as well by hearts from diabetic rats as by those from normal rats. This degree of ischemia accelerated glucose use in normal but not in diabetic hearts. Mild ischemia resulted in increased tissue levels of acyl esters of CoA and camitine in both normal and diabetic hearts, but the rise was greater in the diabetic tissue. A more severe form of ischemia resulted in a faster rate of ventricular failure in hearts from both normal and diabetic rats, but the rate of failure was fastest in the diabetic hearts. This earlier mechanical failure in diabetic tissue was associated with a more rapid rise in tissue long-chain acyl-CoA and acyl camitine esters. Tissue K + was lost during ischemic perfusion to about the same extent in both normal and diabetic hearts. Thus, early pump failure of diabetic hearts in response to ischemia was not associated with a greater loss of cellular K\ Ore Res 44: [322][323][324][325][326][327][328][329] 1979 
Effects of Ischemia on Rat Myocardial Function and Metabolism in Diabetes
DANIELLE FEUVRAY, JANE A. IDELL-WENGER, AND JAMES R. NEELY SUMMARY The function and metabolism of hearts removed from diabetic rats and subsequently . perfused in vitro were investigated. Diabetic hearts perfused under aerobic conditions had higher tissue levels of total CoA and long-chain acyl-CoA, lower levels of total camitine, but higher levels of long-chain acyl camitine esters, and used glucose at slower rates than did normal hearts. At low levels of cardiac work, mechanical function of the diabetic hearts was not significantly different than normal hearts for perfusion periods of up to 65 minutes. A mild form of whole heart ischemia (i.e., a 50% reduction in coronary flow) was tolerated just as well by hearts from diabetic rats as by those from normal rats. This degree of ischemia accelerated glucose use in normal but not in diabetic hearts. Mild ischemia resulted in increased tissue levels of acyl esters of CoA and camitine in both normal and diabetic hearts, but the rise was greater in the diabetic tissue. A more severe form of ischemia resulted in a faster rate of ventricular failure in hearts from both normal and diabetic rats, but the rate of failure was fastest in the diabetic hearts. This earlier mechanical failure in diabetic tissue was associated with a more rapid rise in tissue long-chain acyl-CoA and acyl camitine esters. Tissue K + was lost during ischemic perfusion to about the same extent in both normal and diabetic hearts. Thus, early pump failure of diabetic hearts in response to ischemia was not associated with a greater loss of cellular K\ Ore Res 44: [322] [323] [324] [325] [326] [327] [328] [329] 1979 DIABETES results in a number of diverse alterations in cardiac metabolism. The most noted change is decreased glucose transport into muscle cells (Park et al., 1968; Morgan et al., 1961) . Transport of other compounds such as amino acids (Morgan and Neely, 1972) and ions (Zierler, 1972) may also be affected. Alterations of intracellular metabolism include increased synthesis and tissue levels of glycogen (Neely and Morgan, 1974) , increased tissue levels of lipids (Denton and Randle, 1967) , and net degradation of proteins as a result of alterated rates of both synthesis and degradation of proteins as a result of alterated rates of both synthesis and degradation (Rannels et al., 1975; Rannels, et al., 1977) . Some of these effects have been attributed to the direct action of insulin on membrane function (i.e., glucose transport), whereas others may result indirectly from altered myocardial and whole body metabolism. For example, changes in glycogen, fatty acid, and lipid metabolism may occur in large part as a consequence of increased plasma levels of fatty acids and ketone bodies (Randle et al., 1966) . In hearts removed from diabetic rats, rates of glucose utilization are low, and oxidation of fatty acids supports a greater portion of total energy metabolism (Randle et al., 1966) . These hearts also have higher tissue levels of long-chain acyl-CoA which persist through several minutes of in vitro perfusion in the absence of exogenous fatty acid (Garland and Randle, 1964) . Presumably, this higher level of acyl-CoA represents only a greater fractional conversion of the total CoA to the acyl ester due to increased supply of plasma fatty acids in vivo and to increased release of fatty acids from triglycerides in vitro (Randle et al., 1966) . However, changes in tissue levels of CoA have not been ruled out. Both CoA and camitine are essential cofactors for fatty acid metabolism, and camitine levels have been shown to increase in livers of diabetic animals Foster, 1976, 1977) . The rise in liver camitine is associated with increased oxidation of fatty acid to ketone bodies and decreased conversion of fatty acids to triglycerides. Altered tissue levels of total CoA and camitine in hearts of diabetic animals may be associated with the altered rates of fatty acid metabolism in this tissue.
Whether alterations in myocardial metabolism in diabetics have any direct effects on cardiac function is not clear. Hearts from diabetic rats could not resist anoxic perfusion in vitro as well as normal hearts (Hearse et al., 1975) . The decreased ability to recover function after anoxic perfusion was associated with the inability to use glucose. Longterm diabetes in dogs has been reported to increase ventricular stiffness (Regan, 1975) , and these hearts showed greater reductions in work output in response to regional ischemia (Haider et al., 1977) .
The purpose of the present study was to deter-mine the functional and metabolic response of hearts from diabetic rats to global ischemia in vitro.
Methods
Male Sprague-Dawley rats weighing between 200 and 250 g were used. Severe diabetes was induced by iv injection of alloxan (60 mg/kg body weight) in the femoral vein. Hearts were removed from these rats 48 hours after alloxan injection. To rule out direct toxic effects of alloxan, one group of rats was maintained on insulin for 4 days following alloxan injection, and the insulin treatment was terminated 48 hours before the animals were killed. Function and metabolism of the hearts from these rats were no different than those removed 48 hours after alloxan injection without insulin treatment. In another group of rats used to determine myocardial levels of total CoA and camitine, a less severe form of diabetes was induced by injection of alloxan, 37.5 mg/kg, and these rats were killed at the times indicated in the tables. Diabetes was confirmed in each rat by measuring serum glucose at the time it was killed. Serum glucose was 8 ± 0.3 and 36 ± 4 mM for control and diabetic rats, respectively, in the fed state. Diabetic rats with serum glucose less than 20 mM were not used.
Heart Perfusion
Hearts were removed from the rats and perfused by the working heart technique as described earlier (Neely et al., 1967) . The perfusate was Krebs bicarbonate buffer gassed with a 95% O 2 -5% CO 2 mixture and containing 11 mM glucose. In each case, the perfusate passed through the heart only once. Global ischemia was induced by use of a one-way ball valve in the aortic outflow tract as described earlier (Neely et al., 1973) . Ventricular function was assessed by measuring aortic pressure and heart rate. The product of peak systolic pressure and heart rate was calculated as an estimate of total cardiac pressure developed per minute.
Analytical Methods
Rates of glucose utilization were determined by measuring H 2 O production from [2-3 H]glucose . Tissue levels of CoA and carnitine and their long-chain acyl derivatives were determined as described in Methods of Enzymology (Lowenstein, 1969) . Tissue K + was determined on 3% wt/vol NaCl extracts using a Perkin-Elmer model 360 atomic absorption spe^trophotometer.
Results

Effects of Diabetes on Ventricular Function and Glucose Utilization
It is well known that hearts isolated from diabetic rats have decreased rates of glucose transport and glycolysis and that they use endogenous stores of triglycerides to support mechanical function during short-term perfusion (15 minutes). In the present study, ventricular function and glucose utilization were compared in normal and diabetic hearts ( Fig.  1 ). Hearts from both groups maintained low levels of mechanical function equally well. Mechanical function was maintained in spite of a greatly reduced rate of glucose utilization in the diabetic hearts, indicating that oxidation of endogenous lipids was at least adequate for energy needs at low levels of work output.
Effects of Ischemia on Ventricular Function and Glucose Use in Normal and Diabetic Hearts
It was of interest to determine if alterations in metabolism made the diabetic heart more susceptible to global ischemia. In the working heart preparation, it is possible to reduce coronary flow with a one-way aortic valve which reduces coronary diastolic perfusion (Neely et al., 1973) . Peak systolic pressure is unaltered initially. If the hearts are not electrically paced, coronary flow decreases by 50-60% and O 2 supply is initially decreased by about 30%. In the normal heart, peak pressure is maintained for up to 1 hour, but heart rate decreases. The lower heart rate results in a reduction in energy consumption to match the reduced supply of oxygen. This condition is referred to below as mild ischemia. If the hearts are electrically paced at 300 beats/min, energy utilization is not allowed to de- Hearts were removed from rats that had received alloxan, 37.5 mg/kg, 7 days prior to the experiment. At the time the rats were killed, serum glucose averaged 8 ± 0.5 and 26 ± 3 mM in control and diabetic rats, respectively, in the fed state. The perfusate contained glucose (11 mM). Each heart received a 10-minute washout perfusion prior to beginning the experiment. Ventricular pressure development was adjusted to 60 mm Hg at zero time. Total ventricular function was estimated as the product of peak systolic pressure (PS) and heart rate (HR) and is expressed as mm Hg/min X 7O 3 . Glucose utilization is expressed as \unoles glucoseI g dry per min. Data for control hearts are shown by solid lines and for diabetic hearts by dashed lines. Values are mean ± SEM for six hearts in each group. VOL. 44, No. 3, MARCH 1979 crease by a slower heart rate after ischemia is induced, and ventricular failure is reflected by a decrease in pressure development. The decrease in pressure reduces coronary flow further and function continues to deteriorate. This condition is referred to below as severe ischemia. The response of normal and diabetic hearts to these two types of ischemia was investigated. When coronary flow was reduced after 5 minutes of control perfusion in unpaced hearts, decreased rate in the normal heart resulted in a decrease in the product of peak pressure and rate ( Fig. 2A ). Function was well maintained at this reduced level for an additional 35 minutes. The decrease in function between 35 and 65 minutes was due to a decrease in both heart rate and peak pressure. The diabetic heart, in contrast, had a somewhat higher rate of coronary flow and a lower level of work during the control perfusion (0-5 minutes). Ventric-ular function was less affected by the reduction in coronary flow. The difference in flow between diabetic and normal hearts was evident throughout 60 minutes of ischemic perfusion. Thus the initial reduction in O 2 supply in relation to work output was less in the diabetic heart, which may account for the lack of a decrease in function. As reported earlier (Neely et al., 1975) , a reduction in coronary flow of this magnitude resulted in accelerated rates of glycolysis similar to those shown in Figure 2A . The rate of glucose use in diabetic hearts was low during control perfusion and was increased only slightly over the 60 minutes of ischemic perfusion.
Ventricular function and glycolytic rates of normal and diabetic hearts during 65 minutes of perfusion with normal levels of coronary flow are shown in Figure 2B in the diabetic hearts during the first 40 minutes of perfusion and then began to rise. This late rise in glycolysis probably resulted from a progressive decrease in tissue lipids due to their use for oxidative metabolism (Denton et al., 1967; Randle et al., 1966) . Likewise, the slow steady increase in glycolytic rate in the normal hearts probably resulted from depletion of tissue lipid stores. These data indicate that the diabetic heart is capable of maintaining low levels of cardiac work for extended periods of in vitro perfusion even though the rate of glucose utilization is low. In addition, the inability to utilize glucose did not appear to compromise function under mildly ischemic conditions. Normal or diabetic hearts that receive no reduction in coronary flow can maintain performance for at least 1 hour of perfusion when paced at 300 beats/min (data not shown). However, when coronary flow to electrically paced hearts was reduced, developed ventricular pressure decreased following the initial reduction in coronary flow (Fig. 3) . The rate of decline in pressure development was faster in the diabetic hearts. A decline in peak pressure to 30 mm Hg (9 X 10 3 for peak systolic pressure X heart rate) was arbitrarily chosen to represent ventricular failure. The average time required for diabetic hearts to reach this low level of performance was 2.8 ± 0.4 minutes following the initial reduction in coronary flow (indicated by horizontal lines in Figure 3 ). In contrast, normal hearts required 13 ± 2.4 minutes to reach the same state of failure. As a result of the more rapid failure of pressure development in the diabetic hearts, coronary flow continued to declined at a fast rate following the initial reduction. Glucose utilization (lower panel, Fig. 3 ) was inhibited in normal hearts by this type of severe ischemia as reported earlier (Neely et al., 1975) , and the already low glycolytic rate in diabetic hearts remained low.
Effects of Diabetes and Ischemia on Tissue Levels of CoA, Camitine, and K +
The effects of diabetes on tissue levels of total CoA and camitine are shown in Tables 1 and 2. Tissue levels of total camitine decreased in hearts removed from mildly diabetic animals and assayed immediately (Table 1) . Camitine levels were lower by 7 days and continued to decline through 34 days. The level of total CoA, on the other hand, had increased by 7 days and remained high through 34 days. Also, the level of CoA was higher and camitine was lower in hearts removed from rats 48 hours after injection of 60 mg of alloxan (Table 2) . These changes in diabetic hearts represent a dramatic shift in the whole tissue content of the cofactors involved in fatty acid metabolism and could be expected to have major effects on the intracellular fate of fatty acids.
The levels of acyl-CoA and acyl camitine esters in hearts perfused under control or mildly ischemic Diabetes was induced by injection of alloxan (37.5 mg/kg body weight) and the rats were maintained without insulin treatment for the times indicated before they were killed The hearts were removed from the rats, tnmmed, and blotted, and the ventricles were quickly frozen by clamping between blocks of aluminum cooled in liquid nitrogen. Total tissue CoA and camitine were determined after alkaline hydrolysis of the acyl esters.
Values are mean ± SEM. The number of hearts in each group is shown in parentheses. Diabetes was induced by injection of GO mg of alloxan/kg body weight, and the hearts were removed 48 hours later. Groups of hearts were perfused for 10, 30, and 60 minutes with buffer containing glucose (11 mM). The hearts were quick-frozen by clamping with aluminum blocks cooled in liquid nitrogen, homogenized, hydrolyzed under alkaline conditions, and analyzed for total CoA and camitine. There were no noticeable differences in the levels at various perfusion times and the data have been combined Values are means ± SEM for the number of hearts shown in parentheses.
conditions with buffer containing glucose as the only substrate are shown in Table 3 . Ischemia resulted in increased levels of acyl-CoA and acyl carnitine in both normal and diabetic hearts, but the increase was greater in the diabetic tissue. This increase was still apparent after 60 minutes of perfusion with glucose as the only exogenous substrate. Since diabetic hearts had low rates of glucose usage (Fig. 2) , it might be expected that tissue stores of lipids would be used up during 60 minutes of perfusion, and it is perhaps surprising that acyl esters of CoA and carnitine remained elevated for this time. The hearts used for these analyses were perfused as described for Figure 2 and were frozen at 65 minutes. Long-chain acyl-CoA and acyl carnitine levels were determined on the perchloric acid precipitate as free CoA and carnitine released after alkaline hydrolysis. The values represent mean ± SEM for sii to eight determinations 3 Effects of severe ischemia on ventricular function and glycolytic rate in normal and diabetic hearts. These perfusions were similar to those in Figure  2 , except that the hearts were electrically paced at 300 beats/min starting at zero time. The decline in the product of peak systolic pressure (PSP) and heart rate (HR) thus represents decreased pressure development. Ischemia was induced at 5 minutes (vertical arrow) by reducing coronary flow to about 50% of the preischemic rate. Ventricular pressure development decreased rapidly in both groups, but the decline was faster in diabetic hearts. Since coronary flow depends on peak systolic pressure in this ischemic preparation using a one-way aortic valve, coronary flow also decreased at a faster rate in the diabetic hearts along with developed pressure. The average time required for PSP X HR to decrease to 9 x 10 3 is shown by horizontal bars. This level of function was chosen to represent ventricular failure and corresponds to a PSP of 30 mm Hg. Perfusion of Changes in the levels of acyl-CoA and acyl carnitine were also measured in severely ischemic hearts at early stages of failure (i.e., at the time ventricular failure began, as indicated by the diagonal arrows in Figure 3 ). The levels of acyl esters were higher in diabetic than in normal hearts after 10 minutes of control perfusion (Table 4 ). With short-term ischemia, normal hearts showed no significant rise in long-chain acyl-CoA, but acyl carnitine levels had increased almost 2-fold. In the diabetic hearts, there was a 46% increase in longchain acyl-CoA and a 3-fold increase in long-chain acyl carnitine levels after only 2-3 minutes of ischemic perfusion. A comparison of the acyl esters between normal ischemic and diabetic ischemic hearts indicated that the levels were about 3-fold higher in the diabetic tissue. These data indicate that the earlier onset of ventricular failure in diabetic hearts was associated with increased tissue levels of acyl-CoA and acyl carnitine esters.
It is well known that the ischemic myocardium loses cellular K + and, since both acyl carnitine and insulin may influence K + flux, it was of interest to determine whether tissue K + decreased more rapidly in diabetic hearts exposed to ischemia. After 60 minutes of perfusion under control conditions, diabetic hearts had only slightly less K + than normal controls (P < 0.05) (Fig. 4) . Long-term (60-minute) exposure to mildly ischemic conditions resulted in 4 Effects of diabetes and ischemia on cellular K*. The control (65 minutes) and ischemic hearts (60 minutes) are those perfused for Figure 2 . The 10-minute control and ischemic hearts at failure are the same as those used to obtain the data for Table 4 , and were perfused as described in Figure 3 .
these hearts was continued for an additional 30 minutes following failure. In another group of hearts, the tissue was frozen at the beginning of ventricular failure (times indicated by diagonal arrows) and were used for analysis of CoA, carnitine, and K + . In both cases, the perfusate contained 11 mM glucose. Each point represents mean values from six hearts. Hearts used for these studies were perfused as described for Figure 3 with electrical pacing, but were frozen just at the beginning of ventricular failure (diagonal arrows in Fig. 3 ). The average time of ischemic perfusion was 3 minutes in the diabetic and 7 minutes in the normal. The perfiisate contained glucose as the only exogenous substrate. Control hearts from both normal and diabetic rats were perfused for 10 minutes. Acid-soluble CoA and carnitine, which includes both free and acetyl esters, were determined on the perchlonc acid eitract after alkaline hydrolysis, and the long-chain acyl esters were determined on the perchlonc acid precipitate. Values are means ± SEM for the number of hearts shown in parentheses. about a 25% decrease in cellular K + in both normal and diabetic hearts, but there was no significant difference between the two groups. Also, K + levels were not significantly different in normal and diabetic hearts at the onset of ventricular failure. The levels in ischemic tissue at failure were not significantly different from the 10-minute controls. These data indicate that loss of cellular K + during ischemia does not correlate with increased cellular levels of acyl carnitine or failure of ventricular function.
Discussion
The direct effect of diabetes on myocardial function is poorly understood. Evidence has been presented which indicates that chronic diabetes in the dog results in decreased diastolic ventricular compliance (Regan, 1975) and that the heart of chronically diabetic animals shows greater reductions of function in response to regional ischemia (Haider et al., 1977) . In the present study, diabetic hearts tolerated perfusion under mildly ischemic conditions in vitro just as well as did normal hearts. However, a more severe reduction in the oxygen supply-to-demand ratio did result in a faster rate of ventricular failure in diabetic than in normal hearts. The cause of this effect of diabetes is not known, but changes in glucose and fatty acid metabolism in the diabetic heart may contribute to depressed function under ischemic conditions.
The low rate of glucose use in hearts from diabetic animals results from both insulin deficiency (Park et al., 1968; Morgan et al., 1961) and accelerated use of fatty acid (Morgan et al., 1961; Randle et al., 1966; Kerbey et al, 1976) . The inhibition of glycolysis that is due to fatty acid oxidation cannot be fully corrected by insulin in vitro. This apparently results from higher tissue levels and faster rates of in vitro utilization of triglycerides (Denton and Randle, 1967) . Since oxidation of fatty acids by normal hearts inhibits glucose transport (Neely et al, 1969) , glucose phosphorylation (Randle et al, 1966) , and pyruvate dehydrogenase (Kerbey et al, 1976) , it is reasonable to conclude that faster oxi-dation of endogenous lipids in diabetic hearts may account for their in vitro resistance to insulin stimulation of glucose utilization. However, this inability of diabetic hearts to use glucose does not appear to interfere with their abihty to develop ventricular pressure. In the present study, the rate of use of glucose by diabetic hearts was only about 30% of the rate in normal hearts, but low levels of mechanical function were maintained just as well in normal hearts. Also, rates of oxygen consumption and mechanical function of isolated working rat hearts were not altered by diabetes when the hearts were developing peak pressures of about 135 mm Hg (Opie et al, 1971) . These studies indicate that energy production from oxidation of lipids compensates for reduced glucose use, which allows the diabetic heart to maintain normal function. However, the above studies were conducted in hearts performing less than maximum mechanical work, and it is possible that intrinsic defects in the ability of diabetic hearts to produce ATP and maintain function may not be detected unless the myocardium is stressed to near maximum functional capacity. In the normal isolated rat heart, the maximum pressure development that can be achieved is about 200 mm Hg (Kobayashi and Neely, 1977J . Therefore, the present study with hearts performing low levels of mechanical work, and that reported earlier (Opie et al, 1971) , did not test the maximum work capacity of diabetic hearts. In addition, hearts of diabetic animals may be depressed in vivo due to altered environment, i.e., high plasma fatty acids, ketone bodies, glucose, and H + , and may quickly regain normal function when placed in the in vitro perfusion system with buffer maintained at normal pH and substrate concentrations. A true test of altered ventricular function should include maximum work output in hearts perfused with concentrations of substrates and products simulating the in vivo environment of a diabetic heart.
Another aspect of cardiac metabolism that is greatly altered by diabetes is the tissue levels of metabolites associated with fatty acid oxidation. In addition to higher tissue levels of triglycerides and VOL. 44, No. 3, MARCH 1979 free fatty acids (Denton and Randle, 1967) , levels of long-chain acyl-CoA, acetyl-CoA, and citrate are also elevated (Randle et al., 1966) . In the present study, tissue levels of both long-chain acyl-CoA and acyl carnitine were higher in diabetic hearts perfused under aerobic conditions. This difference was still evident even after 60 minutes of perfusion with glucose as the only substrate available, suggesting that tissue lipid stores were adequate to maintain oxidative metabolism even for prolonged periods of in vitro perfusion.
Ischemia greatly elevates tissue levels of both acyl-CoA and acyl carnitine, particularly when exogenous fatty acids are available (Whitmer et al., 1978) . High tissue levels of these long-chain acyl esters have been shown to inhibit several enzyme systems, and their accumulation in ischemic myocardium has been implicated in the deterioration of energy metabolism and ventricular function. Longchain acyl-CoA inhibits adenine nucleotide transport in isolated mitocnondria (Chua and Shrago, 1977) , but there is no evidence that this inhibition occurs in the intact tissue. Long-chain acyl carnitine inhibits Na + ,K + -ATPase (Wood et al., 1977) and sarcoplasmic reticulum Ca 2+ -ATPase and Ca 2+ uptake (Cohen et al., 1978) . Again, it is not known if these effects are expressed in the intact cell. However, levels of acyl carnitine do increase in the ischemic myocardium to concentrations in excess of that needed for inhibition in vitro. High levels of tissue free fatty acids may also contribute to decreased function of ischemic myocardium (Lamers and Hulsmann, 1977) , but in the present study, no exogenous fatty acid was present, and tissue levels of free fatty acids would be expected to be low.
The diabetic heart may be more affected by accumulation of free fatty acids and acyl esters of CoA and carnitine during ischemia. These hearts not only had increased levels of acyl esters under aerobic conditions, but also showed a larger increase under ischemic conditions. The faster rate of ventricular failure in severely ischemic diabetic hearts compared to normal hearts was associated with a more rapid rise in acyl-CoA and acyl carnitine. Tissue free fatty acids were not measured, but the levels of these products of lipolysis may also have increased laong with their CoA and carnitine esters. At the time of failure, levels of acyl esters were 3 times higher in diabetic than in normal ischemic hearts at comparable perfusion times. Since tissue levels of K+ were not altered by diabetes, higher levels of acyl carnitine did not appear to interfere with Na + ,K + pump activity. Although measurement of tissue levels is a gross estimate of K + movement out of the cells, it does suggest that large changes in cellular K + did not occur, and it is unlikely that acyl carnitine inhibition of the Na + ,K + pump was a significant factor in ischemic tissue. Whether acyl carnitine interferes with Ca 2+ metabolism under these conditions remains to be demonstrated, but altered metabolism of Ca 2+ provides an attractive explanation for the rapid failure of the diabetic heart under ischemic conditions. Changes in the total tissue pool of CoA or carnitine in diabetic hearts could greatly alter cellular metabolism of fatty acids. About 95% of the CoA in cardiac muscle is located in the mitochondrial matrix and 95% of the carnitine is cytosolic (Idell-Wenger et al., 1978) . It has been proposed that a high carnitine-to-CoA ratio in the cytosol compared to the mitochondrial matrix directs fatty acids toward mitochondrial oxidation in heart. Liver, on the other hand, normally has a lower cytosolic carnitine-to-CoA ratio and synthesizes large amounts of triglycerides. In diabetic animals, levels of carnitine increase in liver, and fatty acids are directed away from lipid synthesis and toward oxidation to ketone bodies Foster, 1976, 1977) . In the present study, levels of CoA increased and carnitine decreased in hearts from diabetic rats. The cellular localization of these changes in cofactor concentrations is not known, but if the changes are localized to specific cellular compartments, metabolism of fatty acids can be expected to be greatly altered.
Supraventricular Pacemaker Underdrive in the Absence of Sinus Nodal Influences in the Conscious Dog
JEROD M. LOEB, DAVID K. MURDOCK, WALTER C. RANDALL, AND DAVID E. EULER SUMMARY The ability to reduce and maintain heart rate by electrical stimulation (underdrive) was tested in three groups-of chronically instrumented dogs: sinoatrial node intact, ectopic atrial pacemaker produced by injection of rapidly hardening latex into the sinoatrial nodal artery, and idioventricular pacemaker produced by injection of formalin into the atrioventricular node. In the conscious unsedated state, underdrive of sinoatrial or idioventricular pacemakers resulted in competition between driven and intrinsic foci. However, the cycle length of ectopic atrial pacemakers could be increased by 148.4 ± 30.7 msec (P < 0.001) and maintained at that value. Cessation of underdrive resulted in a period of pacemaker suppression similar to that produced following overdrive. Single premature stimuli produced marked cycle length prolongations in dogs with ectopic atrial foci. Total autonomic blockade had no significant effect on the production of underdrive. Thus, the results of the present experiments provide evidence for maintained capture of cardiac pacemakers at rates significantly below intrinsic control and indicate that underdrive varies as a function of pacemaker site. Underdrive may explain the failure of junctional escape in the presence of slower atrial rhythms. Circ Res 44: [329] [330] [331] [332] [333] [334] 1979 IT IS generally recognized that cardiac pacemakers will follow electrical drive at rates in excess of their inherent rate and that the cessation of pacing normally is followed by a period of quiescence called overdrive suppression (Vassalle, 1977) . It has been demonstrated that the susceptibility to overdrive suppression varies such that the sinus node is least susceptible, whereas increasing susceptibility is shown by ectopic atrial, atrioventricular (AV) junctional, and ventricular pacemakers, respectively (Lange, 1965) . Overdrive suppression has also been used to explain the hierarchial dominance of cardiac pacemakers (Vassalle, 1970) . However, it is clear that prolonged drive is not a prerequisite in order to provoke pacemaker suppression. Thus, transitory
